A novel high throughput assay to quantify Epstein-Barr virus neutralizing antibody activity against B-cell and epithelial cell infections for vaccine and therapeutic developments

Immunization with Epstein–Barr Virus Core Fusion Machinery Envelope Proteins Elicit High Titers of Neutralizing Activities and Protect Humanized Mice from Lethal Dose EBV Challenge

(2021) Xinle Cui et al.   Vaccines

DEVELOPMENT OF AN IMPROVED EPSTEIN-BARR VIRUS (EBV) NEUTRALIZING ANTIBODY ASSAY TO FACILITATE DEVELOPMENT OF A PROPHYLACTIC GP350-SUBUNIT EBV VACCINE

(2020) Hui Liu et al.   Mediterranean Journal of Hematology and Infectious Diseases

A Pentavalent Epstein-Barr Virus-Like Particle Vaccine Elicits High Titers of Neutralizing Antibodies against Epstein-Barr Virus Infection in Immunized Rabbits

(2020) Gabriela M. Escalante et al.   Vaccines

Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells

(2019) Wei Bu et al.   IMMUNITY

Predictors of Epstein-Barr virus serostatus in young people in England

(2019) Joanne R. Winter et al.   BMC INFECTIOUS DISEASES

Primary Epstein-Barr virus infection

(2018) Samantha K. Dunmire et al.   JOURNAL OF CLINICAL VIROLOGY

Ephrin receptor A2 is a functional entry receptor for Epstein–Barr virus

(2018) Jia Chen et al.   Nature Microbiology

Epstein–Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update

(2018) Maria K. Smatti et al.   Frontiers in Oncology

Development of a robust, higher throughput green fluorescent protein (GFP)-based Epstein-Barr Virus (EBV) micro-neutralization assay

(2017) Rui Lin et al.   JOURNAL OF VIROLOGICAL METHODS

The Long and Complicated Relationship between Epstein-Barr Virus and Epithelial Cells

(2016) Lindsey M. Hutt-Fletcher   JOURNAL OF VIROLOGY

In-cell infection: a novel pathway for Epstein-Barr virus infection mediated by cell-in-cell structures

(2015) Chao Ni et al.   CELL RESEARCH

Epstein-Barr Virus Glycoprotein gB and gHgL Can Mediate Fusion and Entry in trans, and Heat Can Act as a Partial Surrogate for gHgL and Trigger a Conformational Change in gB

(2014) L. S. Chesnokova et al.   JOURNAL OF VIROLOGY

The Epstein-Barr Virus (EBV) Glycoprotein B Cytoplasmic C-Terminal Tail Domain Regulates the Energy Requirement for EBV-Induced Membrane Fusion

(2014) J. Chen et al.   JOURNAL OF VIROLOGY

Regulation of Epstein-Barr virus reactivation from latency

(2014) Takayuki Murata   MICROBIOLOGY AND IMMUNOLOGY

Efficient replication of Epstein–Barr virus in stratified epithelium in vitro

(2014) Rachel M. Temple et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Assembly and Architecture of the EBV B Cell Entry Triggering Complex

(2014) Karthik Sathiyamoorthy et al.   PLoS Pathogens

EBV primary infection in childhood and its relation to B-cell lymphoma development: A mini-review from a developing region

(2012) Paola A. Chabay et al.   INTERNATIONAL JOURNAL OF CANCER

The biology of EBV infection in human epithelial cells

(2012) Sai Wah Tsao et al.   SEMINARS IN CANCER BIOLOGY

Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins  v 6 or  v 8

(2009) L. S. Chesnokova et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Human antibody titers to Epstein–Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assay

(2009) Junji Sashihara et al.   VIROLOGY